Baseline characteristics
| Overall | CoreValve | Evolut R | P values | |
| (n=113) | (n=60) | (n=53) | ||
| Sex | ||||
| Female | 58 (51) | 33 (55) | 25 (47) | 0.4 |
| Age, years | 84.0 (80.0–88.0) | 85.0 (81.0–88.0) | 83.0 (80.0–87.0) | 0.2 |
| BMI, kg/m2 | 25.6 (22.7–28.6) | 25.0 (22.3–27.4) | 26.1 (23.2–31.9) | 0.2 |
| NYHA | 0.5 | |||
| 0–2 | 33 (29) | 16 (27) | 17 (32) | |
| 3-4 | 80 (71) | 44 (73) | 36 (68) | |
| STS score, % | 5.6±3.4 | 6.3±3.1 | 4.8±3.6 | 0.02 |
| Comorbidities | ||||
| Dyslipidaemia | 82 (73) | 44 (73) | 38 (72) | 0.9 |
| Diabetes mellitus | 33 (29) | 16 (27) | 17 (33) | 0.6 |
| Hypertension | 88 (78) | 47 (78) | 41 (77) | 0.9 |
| COPD | 23 (20) | 11 (18) | 12 (23) | 0.8 |
| PVD | 10 (9) | 8 (13) | 2 (4) | 0.07 |
| Ischaemic heart disease | 47 (42) | 29 (48) | 18 (34) | 0.09 |
| Previous stroke | 11 (10) | 4 (7) | 7 (13) | 0.1 |
| Echocardiographic characteristics | ||||
| Aortic valve area, cm2 | 0.7±0.2 | 0.7±0.2 | 0.7±0.2 | 0.9 |
| Aortic peak velocity, m/s | 4.2±0.7 | 4.2±0.8 | 4.2±0.7 | 0.8 |
| Mean aortic gradient, mm Hg | 44.0±14.5 | 44.4±14.4 | 43.6±14.7 | 0.8 |
| LVEF, % | 57.9±10.9 | 58.5±9.6 | 57.3±11.9 | 0.6 |
Values are number (%), mean±SD or median (IQR).
BMI, body mass index; COPD, chronic obstructive pulmonary disease; LVEF, left ventricular ejection fraction; NYHA, New York Heart Association; PVD, peripheral vascular disease; STS, Society of Thoracic Surgeons.